Claudia Proto

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

Giuseppe Lo Russo, Massimo Moro, Michele Sommariva et al. · Clinical Cancer Research · 2018 · 400 citations · Full text

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

Giovanni Fucà, Giulia Galli, M. Poggi et al. · ESMO Open · 2019 · 203 citations · Full text

Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer

Lucio Crinò, Giuseppe Bronte, Paolo Bidoli et al. · Lung Cancer · 2019 · 154 citations

Neuro-oncology, Brain Metastases, Medicine +7

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 145 citations · Full text

First-line Pembrolizumab, Medicine, Pathology +6

Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme

Francesco Grossi, Lucio Crinò, Antonio Logroscino et al. · European Journal of Cancer · 2018 · 108 citations

Expanded Access Programme, Geriatric Oncology, Cancer Epidemiology +10